Consolidated Statements of Cash Flows
Years ended March 31
(amounts in millions of Canadian dollars) |
|
2007 |
|
2006 |
|
2005 |
Operating Activities |
|
|
|
Restated |
|
Restated |
|
|
|
(Note 1) |
|
(Note 1) |
|
Net earnings (loss) |
$ |
127.4 |
$ |
63.6 |
$ |
(199.6) |
Results of discontinued operations (Note 4) |
|
1.7 |
|
6.0 |
|
(104.8) |
Earnings (loss) from continuing operations |
|
129.1 |
|
69.6 |
|
(304.4) |
Adjustments to reconcile earnings to cash flows from operating activities: |
|
|
|
|
|
|
Impairment of goodwill, tangible and intangible assets (Note 5) |
|
– |
|
– |
|
443.3 |
Depreciation |
|
55.0 |
|
52.5 |
|
55.1 |
Amortization of deferred financing costs |
|
0.8 |
|
2.2 |
|
7.2 |
Amortization and write down of intangible and other assets |
|
15.8 |
|
22.9 |
|
19.7 |
Future income taxes |
|
(14.2) |
|
5.1 |
|
(114.1) |
Investment tax credits |
|
19.3 |
|
(11.8) |
|
(29.2) |
|
24.6 |
|
12.2 |
|
5.5 |
|
Employee future benefit – net |
|
(0.9) |
|
(2.0) |
|
0.9 |
Other |
|
(10.4) |
|
(3.9) |
|
11.2 |
Changes in |
|
20.2 |
|
79.1 |
|
84.2 |
Net cash provided by continuing operating activities |
|
239.3 |
|
225.9 |
|
179.4 |
Net cash provided by discontinued operating activities |
|
– |
|
2.1 |
|
21.6 |
Net cash provided by operating activities |
|
239.3 |
|
228.0 |
|
201.0 |
Investing Activities |
|
|
|
|
|
|
Business acquisitions (net of cash and cash equivalents acquired) (Note 2) |
|
(4.4) |
|
2.6 |
|
(13.8) |
Proceeds from disposal of discontinued operations |
|
(3.8) |
|
|
|
|
(net of cash and cash equivalents disposed) (Note 4, 19) |
|
|
(4.9) |
|
239.4 |
|
Capital expenditures |
|
(158.1) |
|
(130.1) |
|
(118.0) |
Proceeds from sale and leaseback of assets |
|
– |
|
– |
|
43.8 |
Deferred development costs |
|
(3.0) |
|
(1.8) |
|
(9.9) |
Deferred |
|
(5.9) |
|
(0.7) |
|
(1.7) |
Other |
|
(2.9) |
|
( 9.9) |
|
4.2 |
Net cash (used in) provided by continuing investing activities |
|
(178.1) |
|
(144.8) |
|
144.0 |
Net cash used in discontinued investing activities |
|
– |
|
(2.3) |
|
(5.8) |
Net cash (used in) provided by investing activities |
|
(178.1) |
|
(147.1) |
|
138.2 |
Financing Activities |
|
|
|
|
|
|
Net borrowing under revolving unsecured credit facilities (Note 12) |
|
(0.6) |
|
(30.7) |
|
(273.7) |
Proceeds from |
|
45.8 |
|
32.1 |
|
3.4 |
Reimbursement of |
|
(39.8) |
|
(65.7) |
|
(50.5) |
Dividends paid |
|
(9.8) |
|
(9.7) |
|
(24.0) |
Common stock issuance (Note 15) |
|
10.0 |
|
8.0 |
|
3.6 |
Other |
|
(2.1) |
|
11.6 |
|
0.7 |
Net cash provided by (used in) continuing financing activities |
|
3.5 |
|
(54.4) |
|
(340.5) |
Net cash provided by discontinued financing activities |
|
– |
|
1.2 |
|
3.2 |
Net cash provided by (used in) financing activities |
|
3.5 |
|
(53.2) |
|
(337.3) |
Effect of foreign exchange rate changes on cash and cash equivalents |
|
4.4 |
|
(8.1) |
|
(2.3) |
Net increase (decrease) in cash and cash equivalents |
|
69.1 |
|
19.6 |
|
(0.4) |
Cash and cash equivalents at beginning of year |
|
81.1 |
|
61.5 |
|
61.9 |
Cash and cash equivalents at end of year |
$ |
150.2 |
$ |
81.1 |
$ |
61.5 |
Cash and cash equivalents related to: |
|
|
|
|
|
|
Continuing operations |
$ |
150.2 |
$ |
81.1 |
$ |
57.1 |
Discontinued operations (Note 4) |
|
– |
|
– |
|
4.4 |
|
$ |
150.2 |
$ |
81.1 |
$ |
61.5 |
Supplementary Cash Flows Information (Note 19)
The accompanying notes form an integral part of these Consolidated Financial Statements.